DE4120296A1 - Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc. - Google Patents

Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc.

Info

Publication number
DE4120296A1
DE4120296A1 DE19914120296 DE4120296A DE4120296A1 DE 4120296 A1 DE4120296 A1 DE 4120296A1 DE 19914120296 DE19914120296 DE 19914120296 DE 4120296 A DE4120296 A DE 4120296A DE 4120296 A1 DE4120296 A1 DE 4120296A1
Authority
DE
Germany
Prior art keywords
substances
acid
saponin
limonene
cresol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19914120296
Other languages
German (de)
Inventor
Regina Tilgner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19914120296 priority Critical patent/DE4120296A1/en
Publication of DE4120296A1 publication Critical patent/DE4120296A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Prepn. contains tannic acid, glycoside gein, various bitter substances (such as gentiopicrin, swertiamarin, amarogentin), ethereal oils (alpha-pinene, limonene, eugenol, m-cresol and sesquiterpenes), crude slime, diosmin, aesculus saponin/aesin-flanol cpds., glycerides of lauric acid, myristic acid, oleic acid, chref alkaloid acontin, blossoms, carbohydrates, camphor oil -3-O-fructose, fructic acids, dyestuffs, vitamin C, mustard oil glycosides, glucotropaeolin, quercetic and camphor oil -O-glycosides, silicic acid, saponin, equisetonin, flavone, umbelliferone methyl ether, sesquiterpene bisabolol, slime, amino acids, strychnine, brucine, viscotoxin, glycoproterase with arginine, alkaloids (vinblastin and vincristin), catechol tanning substances, panaxic acid (in wild growing types), oestrogen substances, bioflavone, cations, anions, undissociated substances and gaseous substances. USE/ADVANTAGE - Prepn. can be used against AIDS. The prepn. can be applied three times daily (2 ml each time) by intravenous injection to treat AIDS. No details of activity given.

Description

Im Präparat, sind folgende wirksame Inhaltstoffe enthalten:
Gerbstoffe - Glykosid Gein - verschiedene Bitterstoffe, wie:
Gentiopikrin - Swertiamarin - Amarogentin.The preparation contains the following effective ingredients:
Tannins - Glycoside Gein - various bitter substances, such as:
Gentiopikrin - Swertiamarin - Amarogentin.

Ätherische Öle: a: Pinen - Limonen - Eugenol - m - Kresol sowie Sesquiterpene -
Rohschleim - Diosmin - Aesculussaponin/Aesin - Flanolverbindungen Lumarine - Glyzeride der Laurinsäure - Myristinsäure - Ölsäure - Hauptalkoloid Acontin - Blüten - Kohlehydrate - Kämpferol - 3 - O - Früchte Zucker - Fruchtsäuren - Farbstoffe - Vitamin C - Senfölglykosid - Glukotropaeolin - Quercetin und Kämpferol - O - Glykoside - Kieselsäure - Saponin - Equisetonin - Flavone - Umbelliferonmethyläther - Sesquiterpen Bisabolol - Schleim - Aminosäuren - Strychnin - Brucin - Viscotoxin - Glykoproteid mit Arginin - Alkalide = Vinblastin und Vincristin
Catechingerbstoffe - Panaxsäure (bei wildwachsenen Sorten)
Östrogene Stoffe - Bioflavone.Essential oils: a: pinene - limonene - eugenol - m - cresol and sesquiterpenes -
Raw mucus - Diosmin - Aesculus saponin / Aesin - Flanol compounds Lumarine - Glycerides of lauric acid - Myristic acid - Oleic acid - Main alkoid Acontin - Flowers - Carbohydrates - Kaempferol - 3 - O - Fruit sugar - Fruit acids - Colorants - Vitamin C - Mustard oil glycoside - Glucotropaeolin - Quercetin and kaempfer O - glycosides - silica - saponin - equisetonin - flavone - umbelliferone methyl ether - sesquiterpene bisabolol - mucus - amino acids - strychnine - brucine - viscotoxin - glycoprotein with arginine - alkali = vinblastine and vincristine
Catechins - Panaxic acid (for wild varieties)
Estrogenic substances - bioflavones.

Ferner:
Kationen - Anionen - Undissoziierte Stoffe - Gasförmige Stoffe - 3× täglich sollte das Medikament - jeweils zu 2 ml intravenös - verabreicht werden.Further:
Cations - Anions - Undissociated substances - Gaseous substances - The drug should be administered 3 times a day - 2 ml each intravenously.

Die angegebenen Inhaltsstoffe befinden sich in 16 verschiedenen Pflanzensorten.The specified ingredients are in 16 different Plant varieties.

Claims (1)

1. Pflanzliches Kombinationspräparat gegen AIDS, daduch gekennzeichnet, daß es folgende Stoffe enthält:
Gerbstoffe - Glykosid Gein - verschiedene Bitterstoffe, wie:
Gentiopikrin - Swertiamarin - Amarogentin.
Ätherische Öle: a: Pinen - Limonen - Eugenol - m - Kresol sowie Sesquiterpene -
Rohschleim - Diosmin - Aesculussaponin/Aesin - Flanolverbindungen Lumarine - Glyzeride der Laurinsäure - Myristinsäure - Ölsäure - Hauptalkoloid Acontin - Blüten - Kohlehydrate - Kämpferol - 3 - O - Früchte Zucker - Fruchtsäuren - Farbstoffe - Vitamin C - Senfölglykosid - Glukotropaeolin - Quercetin und Kämpferol - O - Glykoside - Kieselsäure - Saponin - Equisetonin - Flavone - Umbelliferonmethyläther - Sesquiterpen Bisabolol - Schleim - Aminosäuren - Strychnin - Brucin - Viscotoxin - Glykoproteid mit Arginin - Alkaloide = Vinblastin und Vincristin
Catechingerbstoffe - Panaxsäure (bei wildwachsenen Sorten)
Östrogene Stoffe - Bioflavone.
Sowie: Kationen - Anionen - Undissoziierte Stoffe - Gasförmige Stoffe -1. Herbal combination preparation for AIDS, characterized in that it contains the following substances:
Tannins - Glycoside Gein - various bitter substances, such as:
Gentiopikrin - Swertiamarin - Amarogentin.
Essential oils: a: pinene - limonene - eugenol - m - cresol and sesquiterpenes -
Raw mucus - Diosmin - Aesculus saponin / Aesin - Flanol compounds Lumarine - Glycerides of lauric acid - Myristic acid - Oleic acid - Main alkoid Acontin - Flowers - Carbohydrates - Kaempferol - 3 - O - Fruit sugar - Fruit acids - Colorants - Vitamin C - Mustard oil glycoside - Glucotropaeolin - Quercetin and kaempfer O - glycosides - silica - saponin - equisetonin - flavone - umbelliferone methyl ether - sesquiterpene bisabolol - mucus - amino acids - strychnine - brucine - viscotoxin - glycoprotein with arginine - alkaloids = vinblastine and vincristine
Catechins - Panaxic acid (for wild varieties)
Estrogenic substances - bioflavones.
As well as: cations - anions - undissociated substances - gaseous substances -
DE19914120296 1991-06-28 1991-06-28 Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc. Ceased DE4120296A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19914120296 DE4120296A1 (en) 1991-06-28 1991-06-28 Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19914120296 DE4120296A1 (en) 1991-06-28 1991-06-28 Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc.

Publications (1)

Publication Number Publication Date
DE4120296A1 true DE4120296A1 (en) 1992-03-19

Family

ID=6434319

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19914120296 Ceased DE4120296A1 (en) 1991-06-28 1991-06-28 Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc.

Country Status (1)

Country Link
DE (1) DE4120296A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032934A1 (en) * 1995-04-18 1996-10-24 The Boots Company Plc 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection
DE19536152A1 (en) * 1995-09-28 1997-07-17 Kastel Hueseyin Medicament for treating AIDS, haemorrhoids, skin disorders and external ulcers
AT407821B (en) * 1998-03-24 2001-06-25 Franz Dr Stueckler MEDIUM BASED ON NATURAL SUBSTANCES
EP1311267A1 (en) * 2000-08-18 2003-05-21 Immunaid Pty Ltd A retroviral immunotherapy
US8524651B2 (en) 2003-10-24 2013-09-03 Immunaid Pty Ltd. Method of therapy
US9122778B2 (en) 2009-05-27 2015-09-01 Biotempus Limited Methods of treating diseases

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508875A1 (en) * 1984-05-16 1985-11-21 Chimicasa Gmbh Method and product for stimulating the immune system
DE3533563A1 (en) * 1985-09-20 1987-03-26 Michael Birzer MEP AIDS composition
EP0295962A2 (en) * 1987-06-18 1988-12-21 Kureha Kagaku Kogyo Kabushiki Kaisha Protein-polysaccharide for treating retroviral infections
DE3801900A1 (en) * 1988-01-23 1989-09-07 Nink Karl Heinz Use of terpene-containing essential oils for controlling Aids and Arc, and pharmaceutical compositions containing them
WO1990004968A1 (en) * 1988-10-31 1990-05-17 University Of North Carolina At Chapel Hill Inhibition of human retroviruses
DE3942638A1 (en) * 1988-12-26 1990-07-12 Masazumi Yoshihara Agent against AIDS virus and cancer - contg. polysaccharide(s) extracted from husks of nuts with aq. alkali soln.
WO1991004045A1 (en) * 1989-09-20 1991-04-04 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508875A1 (en) * 1984-05-16 1985-11-21 Chimicasa Gmbh Method and product for stimulating the immune system
DE3533563A1 (en) * 1985-09-20 1987-03-26 Michael Birzer MEP AIDS composition
EP0295962A2 (en) * 1987-06-18 1988-12-21 Kureha Kagaku Kogyo Kabushiki Kaisha Protein-polysaccharide for treating retroviral infections
DE3801900A1 (en) * 1988-01-23 1989-09-07 Nink Karl Heinz Use of terpene-containing essential oils for controlling Aids and Arc, and pharmaceutical compositions containing them
WO1990004968A1 (en) * 1988-10-31 1990-05-17 University Of North Carolina At Chapel Hill Inhibition of human retroviruses
DE3942638A1 (en) * 1988-12-26 1990-07-12 Masazumi Yoshihara Agent against AIDS virus and cancer - contg. polysaccharide(s) extracted from husks of nuts with aq. alkali soln.
WO1991004045A1 (en) * 1989-09-20 1991-04-04 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JP 64-292464. In: Patents Abstracts of Japan, C-816, March 26,1991,Vol.15,No.123 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032934A1 (en) * 1995-04-18 1996-10-24 The Boots Company Plc 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection
DE19536152A1 (en) * 1995-09-28 1997-07-17 Kastel Hueseyin Medicament for treating AIDS, haemorrhoids, skin disorders and external ulcers
AT407821B (en) * 1998-03-24 2001-06-25 Franz Dr Stueckler MEDIUM BASED ON NATURAL SUBSTANCES
US6605296B1 (en) 1998-03-24 2003-08-12 Numico Research B.V. Natural substances based agent
EP1311267A1 (en) * 2000-08-18 2003-05-21 Immunaid Pty Ltd A retroviral immunotherapy
EP1311267A4 (en) * 2000-08-18 2007-10-24 Immunaid Pty Ltd A retroviral immunotherapy
US8524651B2 (en) 2003-10-24 2013-09-03 Immunaid Pty Ltd. Method of therapy
US9122778B2 (en) 2009-05-27 2015-09-01 Biotempus Limited Methods of treating diseases
US9239904B2 (en) 2009-05-27 2016-01-19 Biotempus Limited Computer systems for treating diseases
US9268908B2 (en) 2009-05-27 2016-02-23 Biotempus Limited Computer systems for treating diseases
US10714208B2 (en) 2009-05-27 2020-07-14 Biotempus Pty Ltd Computer systems for treating diseases

Similar Documents

Publication Publication Date Title
Aati et al. Traditional use of ethnomedicinal native plants in the Kingdom of Saudi Arabia
Soltan et al. Antiviral screening of forty-two Egyptian medicinal plants
Mohammed et al. Secondary metabolites as anti-inflammatory agents
Scott et al. A pharmacognostical study of 26 South African plant species used as traditional medicines
Günaydin a et al. Phytochemical studies on Ruta chalepensİs (LAM.) lamarck
An et al. Screening for anti-inflammatory activities in extracts from Korean herb medicines
Singh et al. Phytopharmacological review of Vitex negundo (Sambhalu)
Hosseinzadeh et al. Review of the pharmacological and toxicological effects of Salvia leriifolia
US7618663B2 (en) Anti-arthritic herbal composition and method thereof
Christensen Polyphenols and polyphenol-derived compounds from plants and contact dermatitis
Ahsan et al. Therapeutic Application, phytoactives and pharmacology of Tinospora cordifolia: An evocative review
DE4120296A1 (en) Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc.
Divya et al. Phytochemical screening of Saraca asoca (Roxb.), De. Wild
Kumar Medicinal properties of Anthocephalus indicus (Kadam): an indigenous medicinal plant
CN114874215A (en) Preparation of matrine composition and its anti-inflammatory and antipruritic application
Cooper et al. Natural products of silk road plants
Pawar et al. Preliminary phytochemical investigations of three species of traditional medicinal plants of Tribal regions of Maharashtra (India)
Ahmad et al. Qualitative and quantitative determination of phytochemicals in Convolvulus leiocalycinus and Haloxylon griffithii
Odeghe et al. Phytochemistry of Achomanes Difformis Stem, Dioscorea Bulbifera Stem Bark, Fadogia Cienkowskii Leaf, Hannoa Klaineana Stem and Vitex Simplicifolia Leaf
Alkari et al. Phytochemical basis of antiinflammatory and ant-microbial activity of Achyranthes aspera
Oshiomah et al. Anti-inflammatory Effects and Acute Toxicity of Methanol Stem Bark Extract of Morus mesozygia Stapf.
Mboneye et al. Preliminary Phytochemical Screening and Quantitative Analysis of Methanol Leaf Extract of Erlangea tomentosa (Oliv. & Hiern) S. Moore (Asteraceae)
Mir-Babayev et al. Plants of the Republic of Azerbaijan with potential medicinal applications. Part III
Gritto et al. GC-MS ANALYSIS OF BIOACTIVE COMPOUNDS IN METHANOLIC EXTRACT OFTHESPESIA POPULNEA (L.) SOL. EX CORREA
George et al. A Study on the Cytotoxicity of plectranthus amboinicus and bacopa monnieri stem Extracts on Lung Cancer Cell Line

Legal Events

Date Code Title Description
OAV Applicant agreed to the publication of the unexamined application as to paragraph 31 lit. 2 z1
8101 Request for examination as to novelty
8122 Nonbinding interest in granting licenses declared
8110 Request for examination paragraph 44
8105 Search report available
8125 Change of the main classification

Ipc: A61K 35/78

8131 Rejection